![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1660696
Á¶Á÷ Áø´Ü ½ÃÀå º¸°í¼ : Á¦Ç° À¯Çüº°, ±â¼úº°, Áúȯº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)Tissue Diagnostics Market Report by Product Type, Technology, Disease, End-User, and Region 2025-2033 |
Á¶Á÷ Áø´Ü ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 58¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â¿¡´Â 98¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 5.64%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.
Á¶Á÷ Áø´ÜÀº Áúº´ÀÇ »ý¹°ÇÐÀû ¹è°æÀ» ÆÄ¾ÇÇϱâ À§ÇØ Æ¯Á¤ Á¶Á÷ »ùÇÃÀ» ºÐ¼®ÇÏ°í °Ë»çÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ¾ÏÀ̳ª ¿°Áõ¼º Áúȯ°ú °°Àº ƯÁ¤ ÁúȯÀ» °¨ÁöÇÏ´Â µ¥ »ç¿ëµÇ¸ç, ¾Ç¼º Á¾¾çÀÇ Á¤È®ÇÑ Á¾·ù¿Í Á¤µµ¸¦ ÆÄ¾ÇÇÏ¿© ÀáÀçÀûÀÎ ¿øÀΰú Ä¡·á¹ýÀ» ÆÄ¾ÇÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. Á¶Á÷ Áø´ÜÀº ¸Å¿ì Á¤È®Çϰí Àú·ÅÇϸç, ÄÚ¾î »ý°ËÀ̳ª °³º¹ »ý°Ë µî ´Ù¾çÇÑ ¹æ¹ýÀ¸·Î ½ÃÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖ±Ù¿¡´Â ¸é¿ªÁ¶Á÷ÈÇÐ(IHC), in situ hybridization(ISH), µðÁöÅÐ º´¸®ÇÐ, Ư¼ö¿°»ö µîÀÇ Ã·´Ü ±â¼úµµ Áø´Ü¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù.
Ãâ»êÀ² °¨¼Ò¿Í Æò±Õ ¼ö¸íÀÇ Áõ°¡·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ³ëÀÎ Àα¸ÀÇ ºñÀ²ÀÌ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ³ëÀÎÀº ¸¸¼ºÁúȯ¿¡ °É¸®±â ½±±â ¶§¹®¿¡ ÀæÀº °Ë»ç¿Í Áø´ÜÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ ¿Ü¿¡µµ ½Ä½À°üÀÇ º¯È, ¾ËÄÚ¿Ã ¼·Ãë Áõ°¡, ½Åü Ȱµ¿ °¨¼Ò µîÀ¸·Î ÀÎÇØ ÀϺΠ»ýȰ½À°üº´ÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ´õºÒ¾î ¸ðµç ¿¬·É´ë¿¡¼ ´Ù¾çÇÑ Á¾·ùÀÇ ¾ÏÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ÀÌ·¯ÇÑ Áø´Ü ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿äÀÇ ±ÞÁõÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù.
The global tissue diagnostics market size reached USD 5.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033.
Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.
Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.
The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc